Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Inflammatory Bowel Disease
100%
Primary Sclerosing Cholangitis
100%
Theraphy
100%
Tauroursodeoxycholic Acid (TUDCA)
100%
Disease Progression
25%
Liver Disease
25%
Relative Risk
25%
95% Confidence Interval
25%
Liver
12%
Clinical Features
12%
Liver Transplantation
12%
Cirrhosis
12%
Longitudinal Cohort Study
12%
Acid Treatment
12%
Non-associated
12%
Prognostic Factors
12%
Cox Regression Analysis
12%
Mayo Risk Score
12%
Liver Biochemistry
12%
Long-term Prognosis
12%
Stage III-IV
12%
Untreated Patients
12%
Gastroesophageal Varices
12%
Day Therapy
12%
Liver-related Outcomes
12%
Medicine and Dentistry
Primary Sclerosing Cholangitis
100%
Ursodeoxycholic Acid
100%
Inflammatory Bowel Disease
100%
Liver Disease
28%
Diseases
28%
Disease Exacerbation
14%
Prevalence
14%
Cohort Analysis
14%
Patient with Inflammatory Bowel Disease
14%
Clinical Feature
14%
Liver Cirrhosis
14%
Liver Transplantation
14%
Proportional Hazards Model
14%
Prognostic Factor
14%
Varices
14%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Primary Sclerosing Cholangitis
100%
Prevalence
12%
Liver Transplantation
12%
Cirrhosis
12%